FDA Inspection 1088438 — Prisma Health

Prisma Health — FEI 3000207045

The FDA completed an inspection of Prisma Health on Apr 11, 2019 in Greenville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 11, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Greenville, SC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.